Cargando…
Vaccine or monoclonal therapy: which is the winning weapon against COVID-19?
Autores principales: | Lo Muzio, Lorenzo, Bizzoca, Maria Eleonora |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260546/ https://www.ncbi.nlm.nih.gov/pubmed/34242802 http://dx.doi.org/10.1016/j.jgar.2021.05.021 |
Ejemplares similares
-
Nasal vaccine or monoclonal therapy: Which is winning weapon against SARS-CoV-2 variants in 2022?
por: Lo Muzio, Lorenzo, et al.
Publicado: (2022) -
Is the tuberculosis vaccine BCG an alternative weapon for developing countries to defeat COVID-19?
por: Gong, Wenping, et al.
Publicado: (2021) -
COVID-19 and periodontitis: reflecting on a possible association
por: Campisi, Giuseppina, et al.
Publicado: (2021) -
Covid-19 Pandemic: What Changes for Dentists and Oral Medicine Experts? A Narrative Review and Novel Approaches to Infection Containment
por: Bizzoca, Maria Eleonora, et al.
Publicado: (2020) -
An effective weapon against biofilm consortia and small colony variants of MRSA
por: Mirani, Zulfiqar Ali, et al.
Publicado: (2020)